Blood Marker Soluble PD-1 Flags Cancer Return After Liver Transplant in Immunotherapy Patients
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
A pretransplant blood test for soluble PD-1 identified liver cancer patients at high risk of tumor recurrence after immunotherapy and ...
A nationwide U.S. insurance claims analysis presented at the ASTRO Annual Meeting found that fewer than 30 percent of early-stage ...
A preliminary French feasibility study detected circulating tumor cells in the blood of patients during laparoscopic surgery for early-stage cervical ...
A case report describes how an early-stage esophageal cancer with seemingly low-risk features produced an explosive cervical lymph node recurrence ...
A structured eight-week cognitive behavioral intervention significantly reduced caregiver burden and improved quality of life among family caregivers of recurrent ...
A randomized phase III Alliance trial found that delivering postoperative radiosurgery in three to five sessions instead of one significantly ...
A Mayo Clinic-led randomized trial found that delivering postoperative stereotactic radiosurgery in three or five fractions instead of one reduced ...
Whole-exome sequencing of liver transplant patients with hepatocellular carcinoma has identified a 13-gene mutation signature that independently predicts tumor recurrence ...
A narrative review of 18 documented cases finds no recurrences or metastases when the rare sweat gland cancer hidradenocarcinoma is ...
Dutch researchers have shown that combining the bladder chemotherapy drug mitomycin C with ATR kinase inhibitors eradicates patient-derived non-muscle invasive ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine